000 01215 a2200349 4500
005 20250513102456.0
264 0 _c19961115
008 199611s 0 0 eng d
022 _a0306-5456
024 7 _a10.1111/j.1471-0528.1996.tb09541.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWallace, E M
245 0 0 _aInhibins and activins: roles in clinical practice.
_h[electronic resource]
260 _bBritish journal of obstetrics and gynaecology
_cOct 1996
300 _a945-56 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aActivins
650 0 4 _aDown Syndrome
_xmetabolism
650 0 4 _aFemale
650 0 4 _aFollicle Stimulating Hormone
_xantagonists & inhibitors
650 0 4 _aForecasting
650 0 4 _aGrowth Substances
_xphysiology
650 0 4 _aHumans
650 0 4 _aHydatidiform Mole
_xmetabolism
650 0 4 _aInhibins
_xanalysis
650 0 4 _aMale
650 0 4 _aOvarian Neoplasms
_xmetabolism
650 0 4 _aPregnancy
700 1 _aHealy, D L
773 0 _tBritish journal of obstetrics and gynaecology
_gvol. 103
_gno. 10
_gp. 945-56
856 4 0 _uhttps://doi.org/10.1111/j.1471-0528.1996.tb09541.x
_zAvailable from publisher's website
999 _c8856498
_d8856498